CorMedix Reports More Than 75% Of Key Data For Neutrolin Phase 3 LOCK-IT 100 Study Has Been Reviewed And Source-Verified And Appoints Paul Chew As Consultant Adviser CMO; Shares Up 24.3% After Hours
Benzinga Newsdesk